| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| CTAG1B |
P78358
|
cancer/testis antigen 1B
|
|
|
0.507 |
0.731 |
| FRA16D |
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
|
0.656 |
0.577 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| PTMAP4 |
|
prothymosin alpha pseudogene 4
|
|
|
0.638 |
0.731 |
| RNASE3 |
P12724
|
ribonuclease A family member 3
|
|
|
0.490 |
0.808 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| ANKRD36B |
Q8N2N9
|
ankyrin repeat domain 36B
|
|
|
0.584 |
0.500 |
| FRTS1 |
|
Fanconi renotubular syndrome
|
|
|
0.599 |
0.654 |
| PPP1R2C |
O14990
|
PPP1R2C family member C
|
Enzyme modulator
|
|
0.478 |
0.846 |
| FOXD2-AS1 |
|
FOXD2 adjacent opposite strand RNA 1
|
|
|
0.644 |
0.423 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| CTAG1A |
P78358
|
cancer/testis antigen 1A
|
|
|
0.508 |
0.731 |
| CASC2 |
|
cancer susceptibility 2
|
|
|
0.612 |
0.462 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| LINC01194 |
|
long intergenic non-protein coding RNA 1194
|
|
|
0.470 |
0.769 |